Impact of chronic obstructive pulmonary disease on procedural outcomes and quality of life in patients with atrial fibrillation undergoing catheter ablation

Journal of Cardiovascular Electrophysiology

Volumn 24, Issue 2, 2013, Pages 148-154

  Gu, Jun ^a   Liu, Xu ^a   Tan, Hongwei ^a   Zhou, Li ^a   Jiang, Weifeng ^a   Wang, Yuanlong ^a   Liu, Yugang ^a   Gu, Jianing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

atrial tachycardia; catheter ablation; COPD; pulmonary vein isolation

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; STEROID;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; ELECTROCARDIOGRAM; EXTRASYSTOLE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GROIN HEMATOMA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERCAPNIA; HYPERTENSION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY VEIN ISOLATION; QUALITY OF LIFE; RECURRENT DISEASE; REPEAT PROCEDURE; SHORT FORM 36; SMOKING; SOCIAL INTERACTION; STEROID THERAPY; SUPRAVENTRICULAR TACHYCARDIA; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; CHINA; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84873411712     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2012.02448.x     Document Type: Article

References (34)

1. Shibata Y, Watanabe T, Osaka D, Abe S, Inoue S, Tokairin Y, Igarashi A, Yamauchi K, Kimura T, Kishi H, Aida Y, Nunomiya K, Nemoto T, Sato M, Konta T, Kawata S, Kato T, Kayama T, Kubota I,: Impairment of pulmonary function is an independent risk factor for atrial fibrillation: The Takahata Study. Int J Med Sci 2011; 8: 514-522.
2. Lainscak M, Dagres N, Filippatos GS, Anker SD, Kremastinos DT,: Atrial fibrillation in chronic non-cardiac disease: Where do we stand Int J Cardiol 2008; 128: 311-315.
3. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH,: Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.
4. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS,: ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 2011; 57: e101-e198.
5. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D,: HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012; 14: 528-606.
6. Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, Khunnawat C, Ngarmukos T,: A new approach for catheter ablation of atrial fibrillation: Mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004; 43: 2044-2053.
7. Pappone C, Oreto G, Rosanio S, Vicedomini G, Tocchi M, Gugliotta F, Salvati A, Dicandia C, Calabrò MP, Mazzone P, Ficarra E, Di Gioia C, Gulletta S, Nardi S, Santinelli V, Benussi S, Alfieri O,: Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: Efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 2001; 104: 2539-2544.
8. Roh SY, Choi JI, Lee JY, Kwak JJ, Park JS, Kim JB, Lim HE, Kim YH,: Catheter ablation of atrial fibrillation in patients with chronic lung disease. Circ Arrhythm Electrophysiol 2011; 4: 815-822.
9. Gu J, Liu X, Wang X, Shi H, Tan H, Zhou L, Gu J, Jiang W, Wang Y,: Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus. Europace 2011; 13: 1256-1261.
10. Wang X, Liu X, Shi H, Gu J, Sun Y, Zhou L, Hu W,: Pulmonary vein isolation combined with substrate modification for persistent atrial fibrillation treatment in patients with valvular heart diseases. Heart 2009; 95: 1773-1783.
11. Earley MJ, Abrams DJ, Staniforth AD, Sporton SC, Schilling RJ,: Catheter ablation of permanent atrial fibrillation: Medium term results. Heart 2006; 92: 233-238.
12. Reynolds MR, Walczak J, White SA, Cohen DJ, Wilber DJ,: Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs. Circ Cardiovasc Qual Outcomes 2010; 3: 615-623.
13. Pauwels RA, Rabe KF,: Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613-620.
14. Huiart L, Ernst P, Suissa S,: Cardiovascular morbidity and mortality in COPD. Chest 2005; 128: 2640-2646.
15. Sidney S, Sorel M, Quesenberry CP, DeLuise C, Lanes S, Eisner MD,: COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005; 128: 2068-2075.
16. Kirchhof P, Lip GY, Van Gelder IC, Bax J, Hylek E, Kääb S, Schotten U, Wegscheider K, Boriani G, Ezekowitz M, Diener H, Heidbuchel H, Lane D, Mont L, Willems S, Dorian P, Vardas P, Breithardt G, Camm AJ,: Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference. Thromb Haemost 2011; 106: 1012-1019.
17. Fabbri LM, Rabe KF,: From COPD to chronic systemic inflammatory syndrome Lancet 2007; 370: 797-799.
18. Higashimoto Y, Yamagata Y, Taya S, Iwata T, Okada M, Ishiguchi T, Sato H, Itoh H,: Systemic inflammation in chronic obstructive pulmonary disease and asthma: Similarities and differences. Respirology 2008; 13: 128-133.
19. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A, Van Wagoner DR,: C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886-2891.
20. Salpeter SR, Ormiston TM, Salpeter EE,: Cardiovascular effects of beta agonists in patients with asthma and COPD: A meta-analysis. Chest 2004; 125: 2309-2321.
21. Hanrahan JP, Grogan DR, Baumgartner RA, Wilson A, Cheng H, Zimetbaum PJ, Morganroth J,: Arrhythmias in patients with chronic obstructive pulmonary disease (COPD). Medicine 2008; 87: 319-328.
22. Huerta C, Lanes SF, Garcia Rodriguez LA,. Respiratory medications and the risk of cardiac arrhythmias. Epidemiology 2005; 16: 360-366.
23. Caglar IM, Dasli T, Turhan Caglar FN, Teber MK, Ugurlucan M, Ozmen G,: Evaluation of atrial conduction features with tissue Doppler imaging in patients with chronic obstructive pulmonary disease. Clin Res Cardiol 2012;101:599-606.
24. Kurotobi T, Iwakura K, Inoue K, Kimura R, Okamura A, Koyama Y, Tosyoshima Y, Ito N, Fujii K,: Multiple arrhythmogenic foci associated with the development of perpetuation of atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 39-45.
25. Lin WS, Tai CT, Hsieh MH, Tsai CF, Lin YK, Tsao HM, Huang JL, Yu WC, Yang SP, Ding YA, Chang MS, Chen SA,: Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation 2003; 107: 3176-3183.
26. Oral H, Chugh A, Good E, Crawford T, Sarrazin JF, Kuhne M, Chalfoun N, Wells D, Boonyapisit W, Gadeela N, Sankaran S, Kfahagi A, Jongnarangsin K, Pelosi F Jr, Bogun F, Morady F,: Randomized evaluation of right atrial ablation after left atrial ablation of complex fractionated atrial electrograms for long-lasting persistent atrial fibrillation. Circ Arrhythm Electrophysiol 2008; 1: 6-13.
27. Hocini M, Nault I, Wright M, Veenhuyzen G, Narayan SM, Jais P, Lim KT, Knecht S, Matsuo S, Forclaz A, Miyazaki S, Jadidi A, O'Neill MD, Sacher F, Clementy J, Haissaguerre M,: Disparate evolution of right and left atrial rate during ablation of long-lasting persistent atrial fibrillation. J Am Coll Cardiol 2010; 55: 1007-1016.
28. Hunter RJ, Diab I, Tayebjee M, Richmond L, Sporton S, Earley MJ, Schilling RJ,: Characterization of fractionated atrial electrograms critical for maintenance of atrial fibrillation: A randomized, controlled trial of ablation strategies (the CFAE AF trial). Circ Arrhythm Electrophysiol 2011; 4: 622-629.
29. Elayi CS, Di Biase L, Bai R, Burkhardt JD, Mohanty P, Sanchez J, Santangeli P, Hongo R, Gallinghouse GJ, Horton R, Bailey S, Zagrodzky J, Beheiry S, Natale A,: Identifying the relationship between the non-PV triggers and the critical CFAE sites post-PVAI to curtail the extent of atrial ablation in longstanding persistent AF. J Cardiovasc Electrophysiol 2011; 22: 1199-1205.
30. Essebag V, Baldessin F, Reynolds MR, McClennen S, Shah J, Kwaku KF, Zimetbaum P, Josephson ME,: Non-inducibility post-pulmonary vein isolation achieving exit block predicts freedom from atrial fibrillation. Eur Heart J 2005; 26: 2550-2555.
31. Crawford T, Chugh A, Good E, Yoshida K, Jongnarangsin K, Ebinger M, Pelosi F Jr, Bogun F, Morady F, Oral H,: Clinical value of noninducibility by high-dose isoproterenol versus rapid atrial pacing after catheter ablation of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2010; 21: 13-20.
32. Talley CH, Wicks MN,: A pilot study of the self-reported quality of life for patients with chronic obstructive pulmonary disease. Heart Lung 2009; 38: 141-150.
33. Erdogan A, Carlsson J, Neumann T, Berkowitsch A, Neuzner J, Hamm CW, Pitschner HF,: Quality-of-life in patients with paroxysmal atrial fibrillation after catheter ablation: Results of long-term follow-up. Pacing Clin Electrophysiol 2003; 26: 678-684.
34. Singh SN, Tang XC, Singh BN, Dorian P, Reda DJ, Harris CL, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD Jr, Lopez B, Raisch DW, Ezekowitz MD,: SAFE-T investigators: Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: A veterans affairs cooperative studies program substudy. J Am Coll Cardiol 2006; 48: 721-730.